|Date set for appeal by ex-doctor in Vegas hepatitis C case|
LAS VEGAS (AP) - The Nevada Supreme Court is scheduling oral arguments April 5 on an appeal by a once-prominent Las Vegas doctor serving 18 years to life in prison for the largest hepatitis C outbreak in state history. Attorneys for Dipak Desai argue ...
KOLO - Sun, 07 Feb 2016 04:11
|Date set for appeal by ex-doctor in hepatitis C case|
News3LV - Sun, 07 Feb 2016 04:11
|Lawsuits claim insurers unfairly refuse pricey hepatitis C drugs|
The complaints allege that two Washington state insurers - Group Health and BridgeSpan insurance, a subsidiary of Regence BlueShield - are unfairly limiting use of hep C drugs based on cost, not medical necessity. Some insurers in the state cover ...
Houston Chronicle - Sat, 06 Feb 2016 16:22
|Lawmaker: Costly hepatitis C drug "a slap in the face to the veterans"|
A Congressional hearing will begin Wednesday in response to a CBS News investigation that showed how a costly new cure for hepatitis C isn't making it to most of the 200,000 U.S. veterans infected with the disease, many as a result of their service.
CBS News - Wed, 03 Feb 2016 04:05
|Congress outraged over hepatitis C treatment VA can't afford|
Their target is Dr. Raymond Schinazi, who played a leading role developing a drug that cures hepatitis C. When he sold his company to pharmaceutical giant Gilead in 2012, he made over $400 million. And he did it all while working seven-eighths of his ...
CBS News - Wed, 03 Feb 2016 16:22
|House: VA gouged on hep C miracle drug it developed|
FedScoop - Wed, 03 Feb 2016 15:18
|California Pays Insurers Millions More For Hepatitis C Drugs|
Private health plans invoiced the state of California $387.5 million to cover high-cost hepatitis C treatments in Medi-Cal between July 2014 and November 2015, when just 3,624 patients received the treatments, according to the California Department of ...
NPR - Thu, 28 Jan 2016 12:09
|California Doles Out Millions to Insurers for Hepatitis C Drugs|
KQED - Wed, 27 Jan 2016 16:56
|Hep C Drug 'Price War' Looming|
Health experts are predicting a "price war" is looming over expensive hepatitis C drugs taken by many older Americans to treat the virus. Merck announced a list price of $54,000 for a 12-week course of Zepatier — a price significantly lower than two ...
Newsmax - Fri, 05 Feb 2016 11:18
|FDA approves new combination product to treat chronic hepatitis C infection|
The Pharmaceutical Journal - Thu, 04 Feb 2016 08:18
|Merck Obtains Approval of ZEPATIER™ in Canada for the Treatment of Chronic ...|
Investing News Network (press release) (registration) (blog) - Thu, 04 Feb 2016 09:54
|Swedish Hospital patients being tested for Hep B, Hep C, HIV|
Roughly 2,900 people who had surgery at Swedish Medical Center the past five months are being notified that they need to be tested for HIV, hepatitis B and hepatitis C as part of an investigation into a now-former surgical technician. 9NEWS at 9 p.m. 02/0.
9NEWS.com - Wed, 03 Feb 2016 11:33
|Swedish Medical Center patients at risk of HIV, hepatitis B, hepatitis C|
HealthLeaders Media - Wed, 03 Feb 2016 22:56
|2900 patients at Colorado hospital may have been exposed to HIV, hepatitis B ...|
New York Daily News - Wed, 03 Feb 2016 16:28
|Ex-employee may have exposed Swedish Medical Center patients to HIV, hepatitis ...|
FOX31 Denver - Wed, 03 Feb 2016 12:37
|Colorado hospital: Patients may be at risk for hepatitis, HIV|
CNN - Wed, 03 Feb 2016 16:45
|Swedish Medical Center says federal, state agencies recommended tests|
The Denver Post - Thu, 04 Feb 2016 17:04
|Merck & Co joins hepatitis C party|
The US Food and Drug Administration has approved a new combination hepatitis C (HCV) treatment from US firm Merck & Co. Zepatier (elbasvir and grazoprevir) joins the growing family of new drugs that can cure the disease without the use of interferon, ...
Royal Society of Chemistry - Mon, 01 Feb 2016 02:22
|In-depth Merck release on new Hep C drug skirts some of the basics|
HealthNewsReview.org - Tue, 02 Feb 2016 09:34
|FDA Approves Zepatier for Treatment of Chronic Hepatitis C Genotypes 1 and 4|
Infection Control Today - Mon, 01 Feb 2016 07:10
|Hep C market poised for pricing rumble as Merck's cheaper med approved|
BioPharma Dive - Mon, 01 Feb 2016 07:56
|FDA OKs Merck Hepatitis C Drug, Adding to Patient Choices|
Sci-Tech Today - Sun, 31 Jan 2016 19:22
|Zepatier Approved as Hep C Treatment|
Pharmacy Times - Tue, 02 Feb 2016 04:08
|FDA approves Zepatier for hepatitis C genotypes 1 and 4|
Clinical Advisor - Mon, 01 Feb 2016 11:41